Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients.
about
Current and Emerging Uses of Statins in Clinical Therapeutics: A ReviewDietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancerPotentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy.Marketed drugs used for the management of hypercholesterolemia as anticancer armament.
P2860
Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Safety and efficacy of the add ...... ic colorectal cancer patients.
@ast
Safety and efficacy of the add ...... ic colorectal cancer patients.
@en
type
label
Safety and efficacy of the add ...... ic colorectal cancer patients.
@ast
Safety and efficacy of the add ...... ic colorectal cancer patients.
@en
prefLabel
Safety and efficacy of the add ...... ic colorectal cancer patients.
@ast
Safety and efficacy of the add ...... ic colorectal cancer patients.
@en
P2093
P2860
P1476
Safety and efficacy of the add ...... tic colorectal cancer patients
@en
P2093
A J ten Tije
H Gelderblom
T van Wezel
P2860
P2888
P304
P356
10.1007/S10637-015-0285-8
P577
2015-09-19T00:00:00Z